| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Principles of Transparency and Best Practice > About > Principles of Transparency and Best Practice


The Korean Journal of Urological Oncology will follow the Principles of Transparency and Best Practice in Scholarly Publishing (https://doaj.org/bestpractice) developed by Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editors (WAME).

Table of Contents

1. Website

The URL of official journal web site is http://www.kuos.or.kr.

2. Name of journal

The Korean Journal of Urological Oncology

3. Peer review process

The Korean Journal of Urological Oncology has an online submission and peer review system at http://kjuo.inforang.com/submission.

All papers, including those invited by the Editor, are subject to peer review. A manuscript is first reviewed for its format and adherence to the aims and scope of the journal. If the manuscript does not fit the aims and scope of the Journal or does not adhere to the Instructions for Authors, it may be returned to the author immediately after receipt and without a review. Before reviewing, all submitted manuscripts are inspected by Similarity Check powered by iThenticate (https://www.crossref.org/services/similarity-check/), a plagiarism-screening tool.

The journal uses a double-blind peer-review process: the reviewers do not know the identity of the authors, and vice versa. All manuscripts undergo peer review by at least two reviewers with relevant expertise who are selected by the editorial board. If the data need professional statistical review by a statistician, statistical editing is performed.

The editorial board has the right to revise and edit the styles and structures of submitted manuscripts within the context if necessary. Once the decision on publication as an accept, revision or reject is made, it is directly notified to the corresponding author. After the final draft of manuscripts are proven to be appropriate according to the publication policies and styles of the journal, the decision of publication is finalized and expected publication date will be given. Rejected manuscripts are not to be considered again.

The editor is responsible for the final decision whether the manuscript is accepted or rejected.

4. Ownership and management

This journal is owned by the publisher, Korean Urological Oncology Society and The Korean Prostate Society.

5. Governing body

The governing body is the journal's editorial board (https://www.kjuo.or.kr/about/editorial.php).

6. Editorial team and contact information

Editorial Board’s website is https://www.kjuo.or.kr/about/editorial.php.

All of the members are responsible to improve the scientific quality of the journal and to implement editorial policy approved by the editorial board.

Publisher
The Korean Urological Oncology Society and The Korean Prostate Society

Editorial Office
Department of Urology, Chung-Ang University Hospital
102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-1819
Fax: +82-2-6294-1406
E-mail: journal@kjuo.or.kr Homepage: http://www.kjuo.or.kr

7. Copyright and licensing

1) Copyright policy
All published papers become the permanent property of the Korean Urological Oncology Society and the Korean Prostate Society. Copyrights of all published materials are owned by the Korean Urological Oncology Society and the Korean Prostate Society. Permission must be obtained from the Korean Urological Oncology Society and the Korean Prostate Society for any commercial use of materials. Every author should sign and submit the copyright transfer agreement forms.

2) Licensing information
The Korean Journal of Urological Oncology is an Open Access Journal. All articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. All contents of the journal are available immediately upon publication without embargo period.

3) Deposit policy
According to the deposit policy (self-archiving policy) of Sherpa/Romeo (http://www.sherpa.ac.uk), authors can archive pre-print (i.e. pre-refereeing), and they can archive post-print (i.e. final draft post-refereeing). Authors can archive publisher's version/PDF.

8. Author fees

The Korean Journal of Urological Oncology (Korean J Urol Oncol, KJUO) doesn't charge article submission and processing fee from the authors. KJUO charges a publication fee of 300,000 won for Fast-tract review and 100,000 won for Standard tract review.

Publication fee has to be paid only if your article gets accepted for publishing. There are colour figure charges additionally.

Authors will receive information about payment of publication fees at the time of acceptance of article. Publication fee has to be paid only if your article gets accepted for publishing.

9. Process for the identification of and dealing with allegations of research misconduct

The editorial board of the Korean Journal of Urological Oncology have carefully examined all submitted manuscripts whether these are abided by the ethical guidelines of the ICMJE and COPE. When the Journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and other issues, the resolving process will follow the flowchart provided by the COPE (http://publicationethics.org/resources/flowcharts). The editorial board of the Korean Journal of Urological Oncology will discuss the suspected cases and reach a decision. The Korean Journal of Urological Oncology will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.

10. Publication ethics

The Korean Journal of Urological Oncology follows the Guideline on Good Publication of COPE (https://publicationethics.org), Recommendations of International Committee of Medical Journal Editors (http://www.icmje.org/recommendations). Our publication ethics are displayed on the Editorial Policy (Research & Publication Ethics) tab of journal homepage.

11. Publishing schedule

The Korean Journal of Urological Oncology is published four times per year (The last day of February, May, August, and November).

12. Access

This is an open access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

13. Archiving

It is accessible without barrier from Korea Citation Index (http://kci.go.kr), KoreaMed (https://www.koreamed.org), or National Library of Korea (http://nl.go.kr) in the event a journal is no longer published.

14. Revenues sources

Revenue sources of journal were from the support of publisher (the Korean Urological Oncology Society and the Korean Prostate Society), Korea Government’s support, author fee, and advertising rates.

15. Advertising

We accept advertising and sponsorship for its printed journal according to the following principles:

  • - Advertising is separate from content. Advertisers and sponsors have no advance knowledge of our editorial contents, nor do the editors have advance knowledge of advertisers. Content is never altered, added, or deleted to accommodate advertising. Advertisers and sponsors have no input regarding any of our editorial decisions or advertising policies.
  • - We reserve the right to decline or cancel any advertisement at any time.
  • - Advertisements for pharmaceutical products must conform to all regulations and policies of the Ministry of Food and Drug Safety, Republic of Korea in every respect.

16. Direct marketing

Journal propagation has been done through the journal website and distribution of introduction pamphlets. Invitations to submit a manuscript are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.

Editorial Office
Department of Urology, Chung-Ang University Hospital
102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-1819   Fax: +82-2-6294-1406   E-mail: journal@kjuo.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Urological Oncology Society and The Korean Prostate Society.                 Developed in M2PI
Close layer
prev next